New treatments are being introduced to help treat hepatitis C patients, however, barriers could block Black Americans from receiving it.

Viral genotype and baseline viral load still influence PI treatment response, but mutations in certain regions of the viral genome appear as new treatment predictors.

Objectives Oral direct-acting antivirals (DAAs) for hepatitis C virus (HCV) have dramatically changed the treatment paradigm. Our aim was to project temporal trends in HCV diagnosis, treatment and ...